Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin added to insulin in overweight adults with type 1 diabetes mellitus
ACTRN12612000660886Phase 3Not yet recruiting
- Sponsor
- Professor Peter Clifton
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in diabetes mellitus type 1 (T1D) and obesity (2 arms), sponsored by Professor Peter Clifton. Primary endpoints: Glycated hemoglobin at 12 months, Body mass index at 12 months and 1 more. Planned start Sep 2012; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)obesity
Beyond the preview
Go deeper on ACTRN12612000660886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000660886.